Compare
Accelerant Holdings vs CorVel Corp vs Enact Holdings, Inc. vs eHealth, Inc.
| Latest fiscal year | Accelerant Holdings ARX | CorVel Corp CRVL | Enact Holdings, Inc. ACT | eHealth, Inc. EHTH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $912.90M | $958.53M | $1.24B | $554.01M |
| Revenue growth (YoY) | +51.5% | +7.0% | +2.8% | +4.1% |
| Gross margin | n/a | 24.3% | n/a | 43.5% |
| Operating margin | n/a | n/a | n/a | 12.0% |
| Net margin | -147.4% | 11.5% | 54.6% | 7.2% |
| Net income | -$1.35B | $110.34M | $674.24M | $40.04M |
| EPS (Diluted) | -$7.49 | $2.14 | $4.52 | -$0.34 |
| Operating cash flow | $445.10M | $155.64M | $724.52M | -$25.34M |
| Free cash flow | n/a | $110.28M | n/a | -$27.59M |
| Cash & equivalents | $1.72B | $233.07M | $582.49M | $73.72M |
| Total assets | $8.26B | $642.99M | $6.89B | $1.26B |
| Total liabilities | $7.54B | $248.75M | $1.54B | $288.82M |
| Shareholders' equity | $697.70M | $394.23M | $5.36B | $591.60M |
| Return on year-end equity | -192.8% | 28.0% | 12.6% | 6.8% |
| Shares outstanding | n/a | 50.91M | 142.21M | 30.99M |
Revenue, most recent five fiscal years
| Fiscal year | Accelerant Holdings | CorVel Corp | Enact Holdings, Inc. | eHealth, Inc. |
|---|---|---|---|---|
| Latest | $912.90M Ended 2025-12-31 | $958.53M Ended 2026-03-31 | $1.24B Ended 2025-12-31 | $554.01M Ended 2025-12-31 |
| 1 year earlier | $602.60M Ended 2024-12-31 | $895.59M Ended 2025-03-31 | $1.20B Ended 2024-12-31 | $532.41M Ended 2024-12-31 |
| 2 years earlier | $344.00M Ended 2023-12-31 | $795.31M Ended 2024-03-31 | $1.15B Ended 2023-12-31 | $452.87M Ended 2023-12-31 |
| 3 years earlier | n/a | $718.56M Ended 2023-03-31 | $1.10B Ended 2022-12-31 | $405.36M Ended 2022-12-31 |
| 4 years earlier | n/a | $646.23M Ended 2022-03-31 | $1.12B Ended 2021-12-31 | $538.20M Ended 2021-12-31 |